MONOKLONALER INTERLEUKIN-31-ANTIKÖRPER
European patent · EP3842456 · In force
Register entry
- Publication number
- EP3842456
- Application number
- EP20194926
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jul 5, 2012
- Published
- Jun 30, 2021
- Granted
- Sep 18, 2024
- Protection ends at the latest
- Jul 4, 2032
- Next annual fee due
- Jul 31, 2027
- IPC classes
- C07K 16/24 (2006.01)G01N 33/53 (2006.01)
- Priority
- US 201161510268 P 21.07.2011
- Divided from
- EP17168574
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Aug 1, 2026
Next annual fee due on
- Next annual fee due on
- 31.07.2026 → 31.07.2027
Published in Swissreg on 01.08.2026
- Aug 1, 2025
Next annual fee due on
- Next annual fee due on
- 31.07.2025 → 31.07.2026
Published in Swissreg on 01.08.2025
- Jun 25, 2025
Change
Published in Swissreg on 25.06.2025
- Jun 25, 2025
Change
Published in Swissreg on 25.06.2025
- Oct 8, 2024
Agent entered
- Representative
- E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich
Published in Swissreg on 08.10.2024
- Sep 18, 2024
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 18.09.2024
Parties
Inventor
Bammert, Gary F.
Kalamazoo, Michigan 49007, US
Dunham, Steven A.
Kalamazoo, Michigan 49007, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.